Biotech

Advaxis Inc (NASDAQ:ADXS) shares fell 8.65% to $8.77 and were unchanged in after-hours trading. Shares have been trading in a 52-week range of $6.47 to $16.30. The company has a market cap of $366.37 at 40.12 million. Advaxis Inc a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Endologix Inc. (NASDAQ:ELGX) reported that Brown Capital Management Llc. has picked up 8,755,102   of common stock as of 2017-03-07. The acquisition brings the aggregate amount owned by Brown Capital Management Llc. to a total of...

CEL-SCI Corporation (NYSEMKT:CVM) shares were up 7.43% on Monday to $0.113 and down 1.60% in after-hours trading to $0.111. The company has a market cap of $22.46 million at 200.97 million shares outstanding. Share prices have been trading in a 52-week range of $0.06 to $0.66. CEL-SCI Corporation is a...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Entellus Medical Inc. (NASDAQ:ENTL) reported that Discovery Group I, Llc. has picked up 1,418,715 of common stock as of 2017-03-06. The acquisition brings the aggregate amount owned by Discovery Group I, Llc. to a total...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Reata Pharmaceuticals Inc. (NASDAQ:RETA) reported that Cpmg Inc. has picked up 3,161,180 of common stock as of 2017-03-06. The acquisition brings the aggregate amount owned by Cpmg Inc. to a total of 3,161,180 representing a...